The BioMed X Institute
A new research team at XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models to understand wound healing and fibrosis.
RIDGEFIELD, CT / ACCESSWIRE / June 5, 2024 / XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. This research team's main objective is to develop complex, physiologically relevant disease models that deepen our understanding of dysfunctional wound healing and fibrosis. The end goal is to study fibrosis, drug delivery strategies, and drug safety in parallel, in an effort to bridge the gap between research and development to improve patient outcomes accurately and efficiently.
The new research team is led by Dr. Lorenzo Talà, Group Leader at XSeed Labs. "Due to insufficient understanding of the mechanisms driving their pathology, therapies to treat fibrotic diseases are limited. The aim of our research group is to develop physiologically relevant in vitro and in silico fibrosis models. By combining both approaches, we will interrogate disease mechanisms, identify drug delivery pathways, and assess drug safety in order to facilitate drug development toward resolving fibrotic tissues."
Christian Tidona, Founder and Managing Director of the BioMed X Institute: "We are pleased that we could successfully translate the innovation model we established in Heidelberg and New Haven to work inside a major pharma research and development campus. We have a long history of successful collaboration with Boehringer Ingelheim at our Heidelberg institute, and we are proud to extend this collaboration to their U.S. headquarters in Ridgefield, Connecticut."
"We are committed to accelerating innovation across fibrotic diseases. This partnership allows us to harness top talent across the biomedical industry and leverage our leading research and development site in the U.S. to discover insights that could help transform the way we treat these diseases," said Carine Boustany, PhD, U.S. Research Site Head and Global Head of Immunology and Respiratory Diseases Research, Boehringer Ingelheim. "In parallel, we will harness these innovative disease model systems to assess the safety of novel anti-fibrotic concepts, and identify better ways to deliver our molecules," said Xiaorong He, PhD, U.S. Development Site Head and Global Head of Development Sciences, Boehringer Ingelheim.
"We are excited to start our first XSeed Labs team at Boehringer Ingelheim in Ridgefield. It is the beginning of a unique innovation model that promotes scientific exchange between major players in biomedical research," says Mark Johnston, CEO of BioMed X USA.
About BioMed X and XSeed Labs
BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world's brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds -- academia and industry -- and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
BioMed X started working with Boehringer Ingelheim in 2015 with a series of joint research projects hosted by the BioMed X Institute in Heidelberg, Germany. The new collaboration model - called XSeed Labs - entails an open innovation incubator embedded in the Boehringer Ingelheim Ridgefield campus in Connecticut, USA.
Contact Information
Flavia-Bianca Cristian
Recruiting & Communications Manager
fbc@bio.mx
+49 6221 426 11 706
Swathi Lingam
Scientific Communication & Editorial Associate
lingam@bio.mx
+49 6221 426 11 27
Related Images
SOURCE: BioMed X Institute & XSeed Labs
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
The First $5M: Andreas Geldstrom from GENERALIFX Shares His AI-Powered Investment Strategies in an Exclusive Webinar13.3.2025 11:30:00 CET | Press release
Live Webinar on March 21st at 18:30 CET - Registration Now Open ZURICH, SWITZERLAND / ACCESS Newswire / March 13, 2025 / GENERALIFX, a leading provider of investment education, is set to host an exclusive live webinar featuring Andreas Geldstrom, a renowned financial strategist and AI-driven trading expert. The event, scheduled for March 21st at 18:30 CET, will reveal the key strategies that have helped traders achieve their first $5 million in profits using AI-powered investment techniques. As the financial industry continues to evolve, artificial intelligence is reshaping trading and investment strategies, enabling traders to identify market opportunities with greater accuracy and efficiency. GENERALIFX has been at the forefront of this revolution, equipping investors with the knowledge and tools needed to navigate the markets successfully. Webinar Highlights: The Role of AI in Trading: How machine learning is transforming market analysis and decision-making. Effective Risk Managemen
MicroVision To Announce Fourth Quarter and Full Year 2024 Results on March 26, 202512.3.2025 16:05:00 CET | Press release
REDMOND, WA / ACCESS Newswire / March 12, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announces that it will report its fourth quarter and full year 2024 financial results on Wednesday, March 26, 2025 after the market close. The Company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Wednesday, March 26, 2025 to discuss the financial results and provide a business update. Analysts and investors may pose questions for management during the live webcast on March 26, 2025, and may submit questions HERE in advance of the conference call. The live webcast and slide presentation can be accessed on the Company's Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing. About MicroVision MicroVision drives global
Curve Energy Corp. And Lot 49 Capital Corp. Sign Definitive Agreement for Amalgamation and TSX Venture Listing11.3.2025 18:35:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / March 11, 2025 / Curve Energy Corp. (the "Company" or "Curve") and Lot 49 Capital Corp. ("Lot 49") are pleased to announce that they have entered into a definitive agreement (the "Definitive Agreement") to combine the two companies (the "Transaction") which will constitute a reverse takeover transaction ("RTO") of Lot 49. The Transaction is structured to facilitate the listing of the combined entity on the TSX Venture Exchange ("TSXV"). The Transaction is expected to be completed by way of a three-cornered amalgamation under the provisions of the Business Corporations Act (British Columbia) whereby a wholly-owned subsidiary of Lot 49 ("SubCo"), will amalgamate with Curve. All of the issued and outstanding common shares of SubCo and Curve following the amalgamation will be immediately exchanged for common shares of Lot 49 ("Lot 49 Shares") on a one-for-one basis. In connection with closing of the Transaction, Lot 49 intends to settle approximately $138,
Bear Robotics' Carti 100 Wins iF DESIGN AWARD 2025, Setting New Standards in Logistics Automation11.3.2025 11:58:00 CET | Press release
REDWOOD CITY, CA / ACCESS Newswire / March 11, 2025 / Bear Robotics is thrilled to announce that its Carti 100 autonomous mobile robot has been awarded the prestigious iF DESIGN AWARD 2025 in the Product category, Robotics discipline. This achievement reinforces Bear Robotics' position as a leader in innovative robotic design for logistics, building upon the success of the Servi Plus award earlier last year. Carti 100 stood out among nearly 11,000 entries from 66 countries, impressing a panel of 131 international design experts. The iF DESIGN AWARD, recognized globally as a symbol of design excellence, underscores Bear Robotics' commitment to merging cutting-edge technology with user-centric design. Designed by Bear Robotics' in-house design and engineering teams in Silicon Valley, Carti 100 is engineered to revolutionize indoor logistics. Capable of carrying loads up to 220 lbs, and offering extensive customization options, Carti 100 integrates seamlessly into diverse operational envi
Formerra Introduces Formerra+ Upgraded Ecommerce Site to Optimize Customer Experience11.3.2025 09:15:00 CET | Press release
Formerra+™ delivers a faster, smarter, and more seamless way to do business with enhanced product search, intuitive navigation, and powerful management tools. ROMEOVILLE, IL / ACCESS Newswire / March 11, 2025 / Formerra, a leader in performance materials distribution, today launched the Formerra+ ecommerce website, now upgraded to deliver a faster, more intuitive, and personalized experience for customers across multiple industries. The enhanced site provides purchasing, engineering, and quality control customers with easy access to ordering and technical information so that they can get the materials they need faster. "Our customers are looking for efficiency, accuracy, and convenience when managing orders and purchasing materials," said Cathy Dodd, Chief Executive Officer at Formerra. "The upgraded Formerra+ online and mobile experience reflects our commitment to delivering the best digital tools and 24/7 ordering experience to customers worldwide." Formerra+ offers simplified naviga
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom